{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:13:35Z","timestamp":1740136415923,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s10072-024-07934-6","type":"journal-article","created":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T01:43:32Z","timestamp":1735350212000},"page":"539-548","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The impacts of the COVID-19 pandemic on Australia\u2019s myasthenia gravis patients: A self-reported survey study"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4751-2102","authenticated-orcid":false,"given":"Pakeeran","family":"Siriratnam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhibin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"McArthur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Reddell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WenWen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Buzzard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,28]]},"reference":[{"issue":"4","key":"7934_CR1","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.bj.2020.04.007","volume":"43","author":"YC Liu","year":"2020","unstructured":"Liu YC, Kuo RL, Shih SR (2020) COVID-19: The first documented coronavirus pandemic in history. Biomed J 43(4):328\u2013333","journal-title":"Biomed J"},{"key":"7934_CR2","doi-asserted-by":"publisher","first-page":"588013","DOI":"10.3389\/fmed.2021.588013","volume":"8","author":"JS Geng","year":"2021","unstructured":"Geng JS, Yu XL, Bao HN et al (2021) Chronic Diseases as a Predictor for Severity and Mortality of COVID-19: A Systematic Review With Cumulative Meta-Analysis. Front Med 8:588013. https:\/\/doi.org\/10.3389\/fmed.2021.588013","journal-title":"Front Med"},{"issue":"6","key":"7934_CR3","first-page":"1","volume":"11","author":"K Singh","year":"2021","unstructured":"Singh K, Kaushik A, Johnson L et al (2021) Patient experiences and perceptions of chronic disease care during the COVID-19 pandemic in India: a qualitative study. BMJ 11(6):1\u201310","journal-title":"BMJ"},{"issue":"1","key":"7934_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s41983-022-00516-3","volume":"58","author":"D Tugasworo","year":"2022","unstructured":"Tugasworo D, Kurnianto A, Retnaningsih et al (2022) The relationship between myasthenia gravis and COVID-19: a systematic review. Egypt J Neurol Psychiatr Neurosurg 58(1):83","journal-title":"Egypt J Neurol Psychiatr Neurosurg"},{"key":"7934_CR5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jpsychires.2021.05.080","volume":"140","author":"ME Czeisler","year":"2014","unstructured":"Czeisler ME, Wiley JF, Facer-Childs ER et al (2014) Mental health, substance use, and suicidal ideation during a prolonged COVID-19-related lockdown in a region with low SARS-CoV-2 prevalence. J Psychiatr Res 140:533\u2013544","journal-title":"J Psychiatr Res"},{"key":"7934_CR6","unstructured":"Mathieu E, Ritchie H, Rodes-Guirao L, et al. Australia: Coronavirus Pandemic Country Profile. Published online at OurWorldInData.org. Accessed February 20, 2023."},{"issue":"2","key":"7934_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Haris","year":"2009","unstructured":"Haris PA, Taylor R, Thielke R et al (2009) Research electronic data capture (REDCap)- a metadata-driven methodology and workflow process for providing translational research informatics. J Biomed Inform 42(2):377\u2013381","journal-title":"J Biomed Inform"},{"issue":"12","key":"7934_CR8","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S1474-4422(20)30413-0","volume":"19","author":"S Muppidi","year":"2020","unstructured":"Muppidi S, Guptill JT, Jacob S et al (2020) COVID-19-associated risks and effects in myasthenia gravis (CARE-MG). Lancet Neurol 19(12):970\u2013971","journal-title":"Lancet Neurol"},{"issue":"1","key":"7934_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12883-022-02564-x","volume":"22","author":"LP Digala","year":"2022","unstructured":"Digala LP, Prasanna S, Rao P et al (2022) Impact of COVID-19 infection among myasthenia gravis patients- a cerner real-world DataTM study. BMC Neurol 22(1):38","journal-title":"BMC Neurol"},{"key":"7934_CR10","first-page":"100158","volume":"8","author":"L Semenzato","year":"2021","unstructured":"Semenzato L, Botton J, Drouin J et al (2021) Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people. Lancet Reg Health 8:100158","journal-title":"Lancet Reg Health"},{"issue":"4","key":"7934_CR11","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/mus.27497","volume":"65","author":"OG Tuncer","year":"2022","unstructured":"Tuncer OG, Deymeer F (2022) Clinical course and outcome of an outpatient clinic population with myasthenia gravis and COVID-19. Muscle Nerve 65(4):447\u2013452","journal-title":"Muscle Nerve"},{"issue":"16","key":"7934_CR12","doi-asserted-by":"publisher","first-page":"e2109","DOI":"10.1212\/WNL.0000000000011669","volume":"96","author":"G Sole","year":"2021","unstructured":"Sole G, Mathis S, Friedman D et al (2021) Impact of Coronavirus Disease 2019 in a French Cohort of Myasthenia Gravis. Neurology 96(16):e2109-20","journal-title":"Neurology"},{"key":"7934_CR13","doi-asserted-by":"publisher","first-page":"1029190","DOI":"10.3389\/fpubh.2022.1029190","volume":"10","author":"SA Kharroubi","year":"2020","unstructured":"Kharroubi SA, Diab-El-Harake M (2020) Sex-differences in COVID-19 diagnosis, risk factors and disease comorbidities: A large US-based cohort study. Front Public Health 10:1029190","journal-title":"Front Public Health"},{"key":"7934_CR14","doi-asserted-by":"crossref","unstructured":"Butler C, Hobbs R, Gbinigie, et al. Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): Preliminary Analysis from the United Kingdom Randomised, Controlled Open-Label, Platform Adaptive Trial. https:\/\/papers.ssrn.com\/sol3\/papers.cfm?abstract_id=4237902. Published October 4, 2022. Accessed December 1, 2022.","DOI":"10.2139\/ssrn.4237902"},{"issue":"4","key":"7934_CR15","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3988\/jcn.2017.13.4.325","volume":"13","author":"HY Seok","year":"2017","unstructured":"Seok HY, Shin HY, Kim JK et al (2017) The Impacts of Influenza Infection and Vaccination on Exacerbation of Myasthenia Gravis. J Clin Neurol 13(4):325\u2013330","journal-title":"J Clin Neurol"},{"issue":"4","key":"7934_CR16","doi-asserted-by":"publisher","first-page":"e239834","DOI":"10.1001\/jamanetworkopen.2023.9834","volume":"6","author":"M Alcantara","year":"2023","unstructured":"Alcantara M, Koh M, Park AL et al (2023) Outcomes of COVID-19 Infection and Vaccination Among Individuals with Myasthenia Gravis. JAMA Netw Open 6(4):e239834","journal-title":"JAMA Netw Open"},{"issue":"2","key":"7934_CR17","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3390\/neurolint14020033","volume":"14","author":"A Lupica","year":"2022","unstructured":"Lupica A, Di Stefano VD, Iacono S et al (2022) Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort. Neurol Int 14(2):406\u2013416","journal-title":"Neurol Int"},{"issue":"4","key":"7934_CR18","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3390\/life13041064","volume":"13","author":"E Scarsi","year":"2023","unstructured":"Scarsi E, Massucco S, Ferraro PM et al (2023) Comparing the Impact of COVID-19 on Vaccinated and Unvaccinated Patients Affected by Myasthenia Gravis. Life 13(4):1064","journal-title":"Life"},{"key":"7934_CR19","unstructured":"Kirby Institute. Seroprevalence of SARS-CoV-2-specific antibodies among Australian blood donors: Round 2 update. https:\/\/kirby.unsw.edu.au\/sites\/default\/files\/kirby\/report\/COVID19-Blood-Donor-Report-May-Jun-2022_0.pdf. Published July 26, 2022. Accessed August 13, 2022."},{"key":"7934_CR20","unstructured":"Australian Government. COVID-19 Vaccine Roll-Out. COVID-19 vaccine rollout update \u2013 18 July 2022 (health.gov.au). Published July 18, 2022. Accessed December 12, 2022."},{"issue":"1","key":"7934_CR21","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1089\/heq.2020.0031","volume":"4","author":"M Camacho-Rivera","year":"2020","unstructured":"Camacho-Rivera M, Islam JY, Vidot DC (2020) Associations Between Chronic Health Conditions and COVID-19 Preventive Behaviors Among a Nationally Representative Sample of U.S. Adults: An Analysis of the COVID Impact Survey. Health Equity 4(1):336\u2013344","journal-title":"Health Equity"},{"issue":"1","key":"7934_CR22","first-page":"961","volume":"12","author":"TC Hansel","year":"2022","unstructured":"Hansel TC, Saltzman LY, Melton PA et al (2022) COVID-19 behavioural health and quality of life. Nature 12(1):961","journal-title":"Nature"},{"key":"7934_CR23","doi-asserted-by":"crossref","unstructured":"Kalita J, Tripathi A, Dongre N, Misra UK (2021) Impact of COVID-19 pandemic and lockdown in a cohort of myasthenia gravis patients in India. Clin Neurol Neurosurg 202:10648, 8","DOI":"10.1016\/j.clineuro.2021.106488"},{"issue":"19","key":"7934_CR24","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1001\/jama.2022.7281","volume":"327","author":"R Rubin","year":"2022","unstructured":"Rubin R (2022) The COVID-19 Pandemic Rages on for People Who are Immunocompromised. JAMA 327(19):1853\u20131855","journal-title":"JAMA"},{"key":"7934_CR25","first-page":"100048","volume":"2","author":"RG Cowden","year":"2021","unstructured":"Cowden RG, Davis EB, Counted V et al (2021) Suffering, Mental Health, and Psychological Well-being During the COVID-19 Pandemic: A Longitudinal Study of US Adults With Chronic Health Conditions Wellbeing. Space Soc 2:100048","journal-title":"Space Soc"},{"issue":"3","key":"7934_CR26","doi-asserted-by":"publisher","first-page":"101085","DOI":"10.1016\/j.dhjo.2021.101085","volume":"14","author":"D Pettinicchio","year":"2021","unstructured":"Pettinicchio D, Maroto M, Chai L, Lukk M (2021) Findings from an online survey on the mental health effects of COVID-19 on Canadians with disabilities and chronic health conditions. Disabil Health J 14(3):101085","journal-title":"Disabil Health J"},{"issue":"10","key":"7934_CR27","first-page":"543","volume":"5","author":"R Williams","year":"2020","unstructured":"Williams R, Jenkins DA, Ashcroft DM et al (2020) Diagnosis of physical and mental health conditions in primary care during the COVID-19 pandemic: a retrospective cohort study. The Lancet 5(10):543\u2013550","journal-title":"The Lancet"},{"issue":"1","key":"7934_CR28","doi-asserted-by":"publisher","first-page":"e2840","DOI":"10.1002\/brb3.2840","volume":"13","author":"J Nadali","year":"2023","unstructured":"Nadali J, Ghavampour N, Beiranvand F et al (2023) Prevalence of depression and anxiety among myasthenia gravis (MG) patients: A systematic review and meta-analysis. Brain Behav 13(1):e2840","journal-title":"Brain Behav"},{"issue":"7","key":"7934_CR29","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.jocn.2015.01.022","volume":"22","author":"S Blum","year":"2015","unstructured":"Blum S, Lee D, Gillis D et al (2015) Clinical features and impact of myasthenia gravis disease in Australian patients. J Clin Neurosci 22(7):1164\u20131169","journal-title":"J Clin Neurosci"},{"issue":"7","key":"7934_CR30","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.nmd.2021.05.006","volume":"31","author":"AM Ruiter","year":"2021","unstructured":"Ruiter AM, Strijbos E, de Meel RHP et al (2021) Accuracy of patient-reported data for an online patient registry of autoimmune myasthenia gravis and Lambert-Eaton myasthenic syndrome. Neuromuscul Disord 31(7):622\u2013632","journal-title":"Neuromuscul Disord"},{"key":"7934_CR31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jocn.2023.09.023","volume":"118","author":"J Sansoni","year":"2023","unstructured":"Sansoni J, Menon N, Viali L et al (2023) Clinical features, treatments, their impact, and quality of life for Myasthenia Gravis patients in Australia. J Clin Neurosci 118:16\u201322","journal-title":"J Clin Neurosci"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07934-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-024-07934-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07934-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T09:18:37Z","timestamp":1737969517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-024-07934-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,28]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["7934"],"URL":"https:\/\/doi.org\/10.1007\/s10072-024-07934-6","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2024,12,28]]},"assertion":[{"value":"31 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical publication statement"}},{"value":"Pakeeran Siriratnam has received travel support from\u00a0Novartis\u00a0and Biogen. Katherine Buzzard has received speakers honoraria and\/or educational support from Biogen, Sanofi Genzyme, Merck, Roche, Alexion and Teva and has served on medical advisory boards for Merck and Biogen. Stephen Reddel has received speaker\u2019s honoraria and\/or educational support from CSL and Grifols and serves on the National immunoglobulin government advisory committee, relevant to the subject matter of this paper. No disclosure from other authors.The study was conducted anonymously through members of Myasthenia Alliance Australia- no patient identifiers were collected.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures of conflicts of interest"}},{"value":"All authors have agreed the contents of the submission.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Date: 31\/8\/2024"}}]}}